{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:23:03Z","timestamp":1786994583880,"version":"build-2736575974"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100006501","name":"Cystic Fibrosis Foundation Therapeutics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006501","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009210","name":"Food and Drug Administration","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009210","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.nano.2020.102262","type":"journal-article","created":{"date-parts":[[2020,7,3]],"date-time":"2020-07-03T02:59:57Z","timestamp":1593745197000},"page":"102262","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Dry powder aerosol containing muco-inert particles for excipient enhanced growth pulmonary drug delivery"],"prefix":"10.1016","volume":"29","author":[{"given":"Guihong","family":"Chai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amr","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuo","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihua","family":"Lou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell","family":"Simmers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce K.","family":"Rubin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi (Tony)","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. Worth","family":"Longest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Hindle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingguo","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nano.2020.102262_bb0005","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1056\/NEJMra0910061","article-title":"Airway mucus function and dysfunction","volume":"363","author":"Fahy","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nano.2020.102262_bb0010","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1378\/chest.08-0412","article-title":"Mucins, mucus, and sputum","volume":"135","author":"Voynow","year":"2009","journal-title":"Chest"},{"key":"10.1016\/j.nano.2020.102262_bb0015","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.prrv.2007.02.004","article-title":"Mucus structure and properties in cystic fibrosis","volume":"8","author":"Rubin","year":"2007","journal-title":"Paediatr Respir Rev"},{"key":"10.1016\/j.nano.2020.102262_bb0020","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1378\/chest.115.4.1120","article-title":"Emerging therapies for cystic fibrosis lung disease","volume":"115","author":"Rubin","year":"1999","journal-title":"Chest"},{"key":"10.1016\/j.nano.2020.102262_bb0025","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1056\/NEJMra043184","article-title":"Cystic fibrosis","volume":"352","author":"Rowe","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nano.2020.102262_bb0030","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1574-6968.2009.01704.x","article-title":"Cystic fibrosis infections: treatment strategies and prospects","volume":"300","author":"George","year":"2009","journal-title":"FEMS Microbiol Lett"},{"key":"10.1016\/j.nano.2020.102262_bb0035","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.jcf.2012.10.004","article-title":"Treatment of lung infection in patients with cystic fibrosis: current and future strategies","volume":"11","author":"Doring","year":"2012","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.nano.2020.102262_bb0040","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S1357-4310(99)01506-3","article-title":"Cystic fibrosis: an inherited susceptibility to bacterial respiratory infections","volume":"5","author":"Tummler","year":"1999","journal-title":"Mol Med Today"},{"key":"10.1016\/j.nano.2020.102262_bb0045","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1164\/rccm.200705-664OC","article-title":"Cystic fibrosis pulmonary guidelines: chronic medications for maintenance of lung health","volume":"176","author":"Flume","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.nano.2020.102262_bb0050","first-page":"179","article-title":"Tobramycin administered by the TOBI\u00ae Podhaler\u00ae for persons with cystic fibrosis: a review","volume":"4","author":"Vandevanter","year":"2011","journal-title":"Med Devices (Auckl)"},{"key":"10.1016\/j.nano.2020.102262_bb0055","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.ejps.2013.04.011","article-title":"Evaluation and modification of commercial dry powder inhalers for the aerosolization of a submicrometer excipient enhanced growth (EEG) formulation","volume":"49","author":"Son","year":"2013","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.nano.2020.102262_bb0060","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.addr.2014.10.022","article-title":"Inhaled formulations and pulmonary drug delivery systems for respiratory infections","volume":"85","author":"Zhou","year":"2015","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.nano.2020.102262_bb0065","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1517\/17425247.2015.977783","article-title":"Dry powder inhalers in COPD, lung inflammation and pulmonary infections","volume":"12","author":"Muralidharan","year":"2015","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1016\/j.nano.2020.102262_bb0070","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1053\/rmed.2001.1276","article-title":"Evolution of dry powder inhaler design, formulation, and performance","volume":"96","author":"Newman","year":"2002","journal-title":"Respir Med"},{"key":"10.1016\/j.nano.2020.102262_bb0075","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1177\/0091270006295788","article-title":"Lung deposition of radiolabeled tiotropium in healthy subjects and patients with chronic obstructive pulmonary disease","volume":"47","author":"Brand","year":"2007","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.nano.2020.102262_bb0080","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ijpharm.2013.01.003","article-title":"Aerosolization characteristics of dry powder inhaler formulations for the excipient enhanced growth (EEG) application: effect of spray drying process conditions on aerosol performance","volume":"443","author":"Son","year":"2013","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2020.102262_bb0085","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1111\/j.2042-7158.2012.01476.x","article-title":"Condensational growth of combination drug-excipient submicrometer particles for targeted high-efficiency pulmonary delivery: evaluation of formulation and delivery device","volume":"64","author":"Hindle","year":"2012","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.nano.2020.102262_bb0090","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1080\/02786826.2011.566592","article-title":"Numerical model to characterize the size increase of combination drug and hygroscopic excipient nanoparticle aerosols","volume":"45","author":"Longest","year":"2011","journal-title":"Aerosol Sci Technol"},{"key":"10.1016\/j.nano.2020.102262_bb0095","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1164\/ajrccm.162.5.9909009","article-title":"Cystic fibrosis sputum: a barrier to the transport of nanospheres","volume":"162","author":"Sanders","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.nano.2020.102262_bb0100","doi-asserted-by":"crossref","first-page":"365","DOI":"10.2217\/nnm.10.123","article-title":"Rapid transport of muco-inert nanoparticles in cystic fibrosis sputum treated with N-acetyl cysteine","volume":"6","author":"Suk","year":"2011","journal-title":"Nanomedicine (Lond)"},{"key":"10.1016\/j.nano.2020.102262_bb0105","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.addr.2008.09.008","article-title":"Barrier properties of mucus","volume":"61","author":"Cone","year":"2009","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.nano.2020.102262_bb0110","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.1601556","article-title":"Nanoparticles that do not adhere to mucus provide uniform and long-lasting drug delivery to airways following inhalation","volume":"3","author":"Schneider","year":"2017","journal-title":"Sci Adv"},{"key":"10.1016\/j.nano.2020.102262_bb0115","doi-asserted-by":"crossref","first-page":"3887","DOI":"10.1002\/adma.201201800","article-title":"Mucus penetrating nanoparticles: biophysical tool and method of drug and gene delivery","volume":"24","author":"Ensign","year":"2012","journal-title":"Adv Mater"},{"key":"10.1016\/j.nano.2020.102262_bb0120","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1016\/j.biomaterials.2008.12.076","article-title":"The penetration of fresh undiluted sputum expectorated by cystic fibrosis patients by non-adhesive polymer nanoparticles","volume":"30","author":"Suk","year":"2009","journal-title":"Biomaterials"},{"key":"10.1016\/j.nano.2020.102262_bb0125","doi-asserted-by":"crossref","first-page":"9726","DOI":"10.1002\/anie.200803526","article-title":"Addressing the PEG mucoadhesivity paradox to engineer nanoparticles that \"slip\" through the human mucus barrier","volume":"47","author":"Wang","year":"2008","journal-title":"Angew Chem Int Ed"},{"key":"10.1016\/j.nano.2020.102262_bb0130","doi-asserted-by":"crossref","first-page":"8720","DOI":"10.1073\/pnas.1502281112","article-title":"Highly compacted biodegradable DNA nanoparticles capable of overcoming the mucus barrier for inhaled lung gene therapy","volume":"112","author":"Mastorakos","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.nano.2020.102262_bb0135","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.addr.2008.11.002","article-title":"Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues","volume":"61","author":"Lai","year":"2009","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.nano.2020.102262_bb0140","doi-asserted-by":"crossref","first-page":"149ra119","DOI":"10.1126\/scitranslmed.3003594","article-title":"A dense poly(ethylene glycol) coating improves penetration of large polymeric nanoparticles within brain tissue","volume":"4","author":"Nance","year":"2012","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.nano.2020.102262_bb0145","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.addr.2015.09.012","article-title":"PEGylation as a strategy for improving nanoparticle-based drug and gene delivery","volume":"99","author":"Suk","year":"2016","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.nano.2020.102262_bb0150","doi-asserted-by":"crossref","DOI":"10.1007\/s11095-020-02806-y","article-title":"Computational fluid dynamics (CFD) simulations of spray drying: linking drying parameters with experimental aerosolization performance","volume":"37","author":"Longest","year":"2020","journal-title":"Pharm Res"},{"key":"10.1016\/j.nano.2020.102262_bb0155","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.jconrel.2013.05.035","article-title":"Scalable method to produce biodegradable nanoparticles that rapidly penetrate human mucus","volume":"170","author":"Xu","year":"2013","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2020.102262_bb0160","doi-asserted-by":"crossref","first-page":"9217","DOI":"10.1021\/acsnano.5b03876","article-title":"Impact of surface polyethylene glycol (PEG) density on biodegradable nanoparticle transport in mucus ex vivo and distribution in vivo","volume":"9","author":"Xu","year":"2015","journal-title":"ACS Nano"},{"key":"10.1016\/j.nano.2020.102262_bb0165","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1006\/jcis.1996.0217","article-title":"Methods of digital video microscopy for colloidal studies","volume":"179","author":"Crocker","year":"1996","journal-title":"J Colloid Interface Sci"},{"key":"10.1016\/j.nano.2020.102262_bb0170","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.addr.2015.03.017","article-title":"Particle tracking in drug and gene delivery research: State-of-the-art applications and methods","volume":"91","author":"Schuster","year":"2015","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.nano.2020.102262_bb0175","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.88198","article-title":"Microstructural alterations of sputum in cystic fibrosis lung disease","volume":"1","author":"Duncan","year":"2016","journal-title":"JCI Insight"},{"key":"10.1016\/j.nano.2020.102262_bb0180","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1038\/mt.2016.182","article-title":"The mucus barrier to inhaled gene therapy","volume":"24","author":"Duncan","year":"2016","journal-title":"Mol Ther"},{"key":"10.1016\/j.nano.2020.102262_bb0185","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1038\/mt.2014.89","article-title":"Overcoming the cystic fibrosis sputum barrier to leading adeno-associated virus gene therapy vectors","volume":"22","author":"Schuster","year":"2014","journal-title":"Mol Ther"},{"key":"10.1016\/j.nano.2020.102262_bb0190","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1016\/j.biomaterials.2013.01.064","article-title":"Nanoparticle diffusion in respiratory mucus from humans without lung disease","volume":"34","author":"Schuster","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.nano.2020.102262_bb0195","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1089\/jamp.2012.0997","article-title":"Targeting aerosol deposition to and within the lung airways using excipient enhanced growth","volume":"26","author":"Tian","year":"2013","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"key":"10.1016\/j.nano.2020.102262_bb0200","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.nano.2014.09.019","article-title":"Liposome-based mucus-penetrating particles (MPP) for mucosal theranostics: demonstration of diamagnetic chemical exchange saturation transfer (diaCEST) magnetic resonance imaging (MRI)","volume":"11","author":"Yu","year":"2015","journal-title":"Nanomedicine: NBM"},{"key":"10.1016\/j.nano.2020.102262_bb0205","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jconrel.2018.07.001","article-title":"PEGylated enhanced cell penetrating peptide nanoparticles for lung gene therapy","volume":"285","author":"Osman","year":"2018","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2020.102262_bb0210","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jconrel.2014.01.007","article-title":"Lung gene therapy with highly compacted DNA nanoparticles that overcome the mucus barrier","volume":"178","author":"Suk","year":"2014","journal-title":"J Control Release"}],"container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963420301167?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963420301167?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T07:15:45Z","timestamp":1761549345000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1549963420301167"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":42,"alternative-id":["S1549963420301167"],"URL":"https:\/\/doi.org\/10.1016\/j.nano.2020.102262","relation":{},"ISSN":["1549-9634"],"issn-type":[{"value":"1549-9634","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dry powder aerosol containing muco-inert particles for excipient enhanced growth pulmonary drug delivery","name":"articletitle","label":"Article Title"},{"value":"Nanomedicine: Nanotechnology, Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nano.2020.102262","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102262"}}